Target Discovery for RNA Therapeutics workshop at Oligonucleotide Therapeutics Conference 2021
SMi reports: Running alongside the main conference will be an interactive pre-conference workshop on 21st September 2021 on 'Target Discovery for RNA Therapeutics'
By: SMi Group
Featuring Workshop Guest Speakers from: Envisagenics, Eli Lilly, InteRNA Technologies, HAYA Therapeutics, Stoke Therapeutics and ARNAY Sciences
The field of RNA therapeutics has been rapidly gaining momentum. In parallel, methodologies for early discovery have been taking a new form. Combining the now-accessible resources such as big data, multi-omics, and high-performance computing, this new ecosystem of R&D approaches has been surfacing.
This workshop will explore:
Register online: www.oligonucleotide.co.uk/
RNA Therapeutics in Oncology: Advances and Challenges
Gayatri Arun, Vice President of Biology, Envisagenics
Download a copy of your brochure to find out who will be speaking at the upcoming conference in September www.oligonucleotide.co.uk/
Proudly Sponsored by ChemGenes | Genscript | Tosoh Bioscience
SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. For more details and all delegate enquiries please contact Alia Malick on: +44 (0)20 7827 6168.
For media queries please contact Jinna Sidhu at firstname.lastname@example.org or call +44 (0)20 7827 6088.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-